Biogen Inc. buy BMO Capital Markets
Start price
09.11.23
/
50%
€211.40
Target price
09.11.24
€276.44
Performance (%)
-23.23%
End price
10.11.24
€162.30
Summary
This prediction ended on 10.11.24 with a price of €162.30. The prediction for Biogen Inc. disappointed with a performance of -23.23%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -0.251% | -0.251% | 22.901% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $314.00 to $295.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten